COMMONWEALTH EQUITY SERVICES, LLC - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 381 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.

Quarter-by-quarter ownership
COMMONWEALTH EQUITY SERVICES, LLC ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$974
+15.4%
21,470
+4.4%
0.00%0.0%
Q2 2023$844
+14.5%
20,573
-0.3%
0.00%0.0%
Q1 2023$737
-5.6%
20,638
-0.3%
0.00%0.0%
Q4 2022$781
-99.9%
20,704
-2.6%
0.00%0.0%
Q3 2022$939,000
+6.8%
21,247
-10.6%
0.00%0.0%
Q2 2022$879,000
-8.6%
23,764
-8.6%
0.00%0.0%
Q1 2022$962,000
+9.9%
25,993
-9.6%
0.00%0.0%
Q4 2021$875,000
-31.5%
28,766
-24.5%
0.00%
-33.3%
Q3 2021$1,278,000
+24.6%
38,118
+48.1%
0.00%0.0%
Q2 2021$1,026,000
+25.9%
25,730
+41.9%
0.00%
+50.0%
Q1 2021$815,000
-24.1%
18,136
-4.6%
0.00%
-33.3%
Q4 2020$1,074,000
+16.5%
19,006
-2.3%
0.00%0.0%
Q3 2020$922,000
-22.1%
19,444
-3.2%
0.00%
-25.0%
Q2 2020$1,184,000
+28.4%
20,092
+2.9%
0.00%0.0%
Q1 2020$922,000
-18.8%
19,521
+3.8%
0.00%0.0%
Q4 2019$1,136,000
-3.2%
18,811
-4.0%
0.00%
-20.0%
Q3 2019$1,174,000
-6.6%
19,602
+0.2%
0.01%
-16.7%
Q2 2019$1,257,000
-19.3%
19,560
+1.9%
0.01%
-14.3%
Q1 2019$1,557,000
+52.2%
19,186
+1.4%
0.01%
+40.0%
Q4 2018$1,023,000
+9.4%
18,927
+4.4%
0.01%
+25.0%
Q3 2018$935,000
+19.4%
18,135
-3.5%
0.00%0.0%
Q2 2018$783,000
-7.1%
18,795
-1.8%
0.00%
-20.0%
Q1 2018$843,000
-11.5%
19,146
+1.1%
0.01%0.0%
Q4 2017$953,00018,9400.01%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Tweedy, Browne Co LLC 3,510,173$159,221,4478.52%
Bellevue Group AG 9,233,700$418,840,6326.75%
Deep Track Capital, LP 2,834,069$128,553,3704.96%
BVF INC/IL 4,004,613$181,649,2464.90%
Sicart Associates LLC 203,132$9,214,0683.61%
Camber Capital Management LP 2,250,000$102,0603.36%
Privium Fund Management B.V. 228,493$10,364,4433.08%
Orbimed Advisors 2,169,500$98,408,5202.09%
SECTOR GAMMA AS 165,616$7,512,3421.92%
TANAKA CAPITAL MANAGEMENT INC 14,612$6631.89%
View complete list of IONIS PHARMACEUTICALS INC shareholders